ArticleRevista medica del Instituto Mexicano del Seguro Social2026
[Coffin-Lowry syndrome: Case report in Mexico].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coffin-Lowry syndrome (CLS, OMIM #303600) is an X-linked dominant inherited condition caused by variants in the RPS6KA3 gene located at Xp22.12 and mainly affects men. It is associated with various phenotypes, including dysmorphic facial features, neurodevelopmental impairment, short stature, and skeletal deformities. The objective was to present a case of CLS, describe the clinical manifestations found, compare it with what is reported in the literature and collaborate in expanding the phenotypic and molecular spectrum, because it presents a previously unreported variant. Clinical case: A 4-year-old male, son of healthy, non-consanguineous parents, who presents distinctive clinical features of CLS: global neurodevelopmental delay, hypertelorism, low-set and prominent ears, down-slanted palpebral fissures, depressed nasal bridge, anteverted nostrils, wide mouth, widely spaced teeth, and broad fingers. Genetic analysis revealed a likely pathogenic hemizygous variant RPS6KA3 c.1762G>A (p. Glu588Lys) associated with CLS. Conclusions: CLS is a rare entity that is usually diagnosed in childhood. Typical facial changes and specific clinical and radiological signs in the hands are very useful in diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.